Organic Process Research & Development
Article
Espinosa, S.; Lop
́
ez, M.; Sentellas, S.; Gonzal
́
ez, M.; Albertí, J.;
(23) Jia, Z.; Ma, H.; Huang, Y.; Huang, Y.; Ren, P.; Song, S.; Hu, M.;
Tao, Y. Production of (R)-3-quinuclidinol by a whole-cell biocatalyst
with high efficiency. Biocatal. Biotransform. 2018, 36, 316−323.
(24) Noyori, R.; Ohkuma, T. Asymmetric Catalysis by Architectural
and Functional Molecular Engineering: Practical Chemo- and
Stereoselective Hydrogenation of Ketones. Angew. Chem., Int. Ed.
2001, 40, 40−73.
Segarra, V.; Cardenas, A.; Beleta, J.; Ryder, H. Discovery of novel
́
quaternary ammonium derivatives of (3R)-quinuclidinol esters as
potent and long-acting muscarinic antagonists with potential for
minimal systemic exposure after inhaled administration: identification
of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy-1-(3-phenoxypropyl)-1-
azoniabicyclo[2.2.2] octanebromide (aclidinium bromide). J. Med.
Chem. 2009, 52, 5076−5092.
8) Montuschi, P.; Ciabattoni, G. Bronchodilating Drugs for
Chronic Obstructive Pulmonary Disease: Current Status and Future
Trends. J. Med. Chem. 2015, 58, 4131−4164.
9) Gralla, R.; Lichinitser, M.; Van der Vegt, S.; Sleeboom, H.;
Mezger, J.; Pe-schel, C.; Tonini, G.; Labianca, R.; Macciocchi, A.;
Aapro, M. Palonosetron improves prevention of chemotherapy-induce
nausea and vomiting following moderately emetogenic chemotherapy:
results of a double-blind randomized phase III trial comparing single
doses of palonosetron with ondansetron. Ann. Oncol. 2003, 14, 1570−
577.
10) Rabe, K. F; Watz, H. Chronic obstructive pulmonary disease.
Lancet 2017, 389, 1931−1940.
11) Marsh, K.; Zaiser, E.; Orfanos, P.; Salverda, S.; Wilcox, T.; Sun,
(25) Groger, H.; Chamouleau, F.; Orologas, N.; Rollmann, C.;
̈
(
Drauz, K.; Hummel, W.; Weckbecker, A.; May, O. Enantioselective
Reduction of Ketones with “Designer Cells” at High Substrate
Concentrations: Highly Efficient Access to Functionalized Optically
Active Alcohols. Angew. Chem., Int. Ed. 2006, 45, 5677−5681.
(
(26) Kataoka, M.; Kita, K.; Wada, M.; Yasohara, Y.; Hasegawa, J.;
Shimizu, S. Novel bioreduction system for the production of chiral
alcohols. Appl. Microbiol. Biotechnol. 2003, 62, 437−445.
(27) Kizaki, N.; Yasohara, Y.; Hasegawa, J.; Wada, M.; Kataoka, M.;
Shimizu, S. Synthesis of optically pure ethyl (S)-4-chloro-3-
hydroxybutanoate by Escherichia coli transformant cells coexpressing
the carbonyl reductase and glucose dehydrogenase genes. Appl.
Microbiol. Biotechnol. 2001, 55, 590−595.
1
(
(28) Xu, Q.; Tao, W. Y.; Huang, H.; Li, S. Highly efficient synthesis
(
of ethyl (S)-4-chloro-3-hydroxybutanoate by a novel carbonyl
reductase from Yarrowia lipolytica and using mannitol or sorbitol as
cosubstrate. Biochem. Eng. J. 2016, 106, 61−67.
S.; Dixit, S. Evaluation of COPD treatments: A multicriteria decision
analysis of aclidinium and tiotropium in the United States. Value
Health 2017, 20, 132−140.
(29) Bulow, L.; Ljungcrantz, P.; Mosbach, K. Preparation of a
̈
(
12) Tsutsumi, K.; Katayama, T.; Utsumi, N.; Murata, K.; Arai, N.;
soluble biofunctional enzyme by gene fusion. Nat. Biotechnol. 1985, 3,
21−823.
30) Hyde, C. C.; Ahmed, S. A.; Padlan, E. A.; Miles, E. W.; Davies,
Kurono, N.; Ohkuma, T. Practical asymmetric hydrogenation of 3-
Quinuclidinone catalyzed by the XylSkewphos /PICA-Ruthenium
II) complex. Org. Process Res. Dev. 2009, 13, 625−628.
13) Arai, N.; Akashi, M.; Sugizaki, S.; Ooka, H.; Inoue, T.;
Ohkuma, T. Asymmetric Hydrogenation of Bicyclic Ketones
Catalyzed by BINAP/IPHAN-Ru (II) Complex. Org. Lett. 2010, 12,
8
(
(
D. R. Three-dimensional structure of the tryptophan synthase alpha 2
beta2 multienzyme complex from Salmonella typhimurium. J. Biol.
Chem. 1988, 263, 17857−17871.
(
(31) Conrado, R. J.; Varner, J. D.; DeLisa, M. P. Engineering the
3
(
380−3383.
spatial organization of metabolic enzymes: mimicking nature’s
synergy. Curr. Opin. Biotechnol. 2008, 19, 492−499.
14) Nomoto, F.; Hirayama, Y.; Ikunaka, M.; Inoue, T.; Otsuka, K.
Practical chemoenzymatic process to access (R)-quinuclidin-3-ol on
scale. Tetrahedron: Asymmetry 2003, 14, 1871−1877.
15) Wang, Y.; Li, J.; Wu, Q.; Zhu, D. Microbial stereospecific
reduction of 3-quinuclidinone with newly isolated nocardia sp. and
rhodococcus erythropolis. J. Mol. Catal. B: Enzym. 2013, 88, 14−19.
16) Kolet, S. P.; Jadhav, D. D.; Priyadarshini, B.; Swarge, B. N.;
(32) Castellana, M.; Wilson, M. Z.; Xu, Y.; Joshi, P.; Cristea, I. M.;
Rabinowitz, J. D.; Gitai, Z.; Wingreen, N. S. Enzyme clustering
accelerates processing of intermediates through metabolic channeling.
Nat. Biotechnol. 2014, 32, 1011−1018.
(
(33) Iturrate, L.; Sanchez-Moreno, I.; Doyaguez, E. G.; García-
́
̈
(
Junceda, E. Substrate channeling in an engineered bifunctional
aldolase/kinase enzyme confers catalytic advantage for C−C bond
formation. Chem. Commun. 2009, 13, 1721−1723.
Thulasiram, H. V. Fungi mediated production and practical
purification of (R)-(−)-3-quinuclidinol. Tetrahedron Lett. 2014, 55,
5
(
911−5914.
(34) Torres Pazmino, D. E.; Snajdrova, R.; Baas, B.-J.; Ghobrial, M.;
17) Uzura, A.; Nomoto, F.; Sakoda, A.; Nishimoto, Y.; Kataoka, M.;
Mihovilovic, M. D.; Fraaije, M. W. Self-sufficient Baeyer-Villiger
monooxygenases: effective coenzyme regeneration for biooxygenation
by fusion engineering. Angew. Chem., Int. Ed. 2008, 47, 2275−2278.
Shimizu, S. Stereoselective synthesis of (R)-3-quinuclidinol through
asymmetric reduction of 3-quinuclidinone with 3-quinuclidinone
reductase of rhodotorula rubra. Appl. Microbiol. Biotechnol. 2009, 83,
(35) Vahidi, A. K.; Yang, Y.; Ngo, T. P. N.; Li, Z. Simple and
6
(
17−626.
Efficient Immobilization of Extracellular His-Tagged Enzyme Directly
From Cell Culture Supernatant as Active and Recyclable Nano-
biocatalyst: High-Performance Production of Biodiesel from Waste
Grease. ACS Catal. 2015, 5, 3157−3161.
18) Isotani, K.; Kurokawa, J.; Itoh, N. Production of (R)-3-
Quinuclidinol by E. coli biocatalysts possessing NADH-dependent 3-
Quinuclidinone reductase (QNR or bacC) from Microbacterium
luteolum and leifsonia alcohol dehydrogenase (LSADH). Int. J. Mol.
Sci. 2012, 13, 13542−13553.
(36) Holsch, K.; Weuster-Botz, D. Enantioselective reduction of
prochiral ketones by engineered bifunctional fusion proteins.
(
19) Isotani, K.; Kurokawa, J.; Suzuki, F.; Nomoto, S.; Negishi, T.;
Biotechnol. Appl. Biochem. 2010, 56, 131−140.
Matsuda, M.; Itoh, N. Gene Cloning and Characterization of Two
NADH-Dependent 3-Quinuclidinone Reductases from Microbacte-
rium luteolum JCM9174. Appl. Environ. Microbiol. 2013, 79, 1378−
384.
20) Spickermann, D.; Hausmann, S.; Degering, C.; Schwaneberg,
U.; Leggewie, C. Engineering of highly selective variants of
parvibaculum lavamentivorans alcohol dehydrogenase. ChemBioChem
014, 15, 2050−2052.
21) Chen, W.; Cheng, X.; Zhou, Z.; Liu, J.; Wang, H. Molecular
cloning and characterization of a tropinone reductase from
(37) Li, B.; Li, Y.; Bai, D.; Zhang, X.; Yang, H.; Wang, J.; Liu, G.;
Yue, J.; Ling, Y.; Zhou, D.; Chen, H. Whole-cell biotransformation
systems for reduction of prochiral carbonyl compounds to chiral
alcohol in Escherichia coli. Sci. Rep. 2015, 4, 6750.
1
(
(38) Suhrer, I.; Haslbeck, M.; Castiglione, K. Asymmetric synthesis
of a fluoxetine precursor with an artificial fusion protein of a
ketoreductase and a formate dehydrogenase. Process Biochem. 2014,
49, 1527−1532.
2
(
(39) Calam, E.; Gonzalez-Roca, E.; Fernandez, R.; Dequin, S.; Pares,
́ ́ ́
X.; Virgili, A.; Biosca, J. A. Enantioselective Synthesis of Vicinal (R,
R)-Diols by Saccharomyces cerevisiae Butanediol Dehydrogenase.
Appl. Environ. Microbiol. 2016, 82, 1706−1721.
Dendrobium nobile Lindl. Mol. Biol. Rep. 2013, 40, 1145−1154.
22) Zhang, W. X.; Xu, G. C.; Huang, L.; Pan, J.; Yu, H. L.; Xu, J. H.
(
Highly Efficient Synthesis of (R)-3-Quinuclidinol in a Space-Time
(40) Chen, X.; Zaro, J. L.; Shen, W. C. Fusion protein linkers:
Property, design and functionality. Adv. Drug Delivery Rev. 2013, 65,
1357−1369.
Yield of 916 g L−
1
d
−1
Using a New Bacterial Reductase ArQR. Org.
Lett. 2013, 15, 4917−4919.
H
Org. Process Res. Dev. XXXX, XXX, XXX−XXX